Polymorphism rs10105606 of LPL as a Novel Risk Factor for Microalbuminuria

References

• Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
   PubMed Web of Science ®Google Scholar
• Chang B-C-C, Hwang L-C, Huang W-H. Positive association of metabolic syndrome with a single nucleotide polymorphism of Syndecan-3 (rs2282440) in the Taiwanese population. Int J Endocrinol. 2018;2018. doi:10.1155/2018/9282598
   PubMed Web of Science ®Google Scholar
• Povel CM, Boer JMA, Onland-Moret NC, Dollé MET, Feskens EJM, van der Schouw YT. Single nucleotide polymorphisms (SNPs) involved in insulin resistance, weight regulation, lipid metabolism and inflammation in relation to metabolic syndrome: an epidemiological study. Cardiovasc Diabetol. 2012;11:133. doi:10.1186/1475-2840-11-133
   PubMed Web of Science ®Google Scholar
• Saldaña-Alvarez Y, Salas-Martínez MG, García-Ortiz H, et al. Gender-dependent association of FTO polymorphisms with body mass index in Mexicans. PLoS One. 2016;11(1):e0145984. doi:10.1371/journal.pone.0145984
   PubMed Web of Science ®Google Scholar
• Consortium WTCC. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature. 2007;447(7145):661.
   PubMed Web of Science ®Google Scholar
• Huang W-H, Hwang L-C, Chan H-L, Lin H-Y, Lin Y-H. Study of seven single-nucleotide polymorphisms identified in East Asians for association with obesity in a Taiwanese population. BMJ Open. 2016;6(8):e011713. doi:10.1136/bmjopen-2016-011713
   PubMed Web of Science ®Google Scholar
• Berezina A, Belyaeva O, Berkovich O, et al. Prevalence, risk factors, and genetic traits in metabolically healthy and unhealthy obese individuals. Biomed Res Int. 2015;2015:1–9. doi:10.1155/2015/548734
   Web of Science ®Google Scholar
• Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-00007
   PubMed Web of Science ®Google Scholar
• Steemburgo T, de Azevedo MJ, Gross JL, Milagro F, Campión J, Martínez JA. The rs7204609 polymorphism in the fat mass and obesity-associated gene is positively associated with central obesity and microalbuminuria in patients with type 2 diabetes from Southern Brazil. J Ren Nutr. 2012;22(2):228–236. doi:10.1053/j.jrn.2011.03.004
   PubMed Web of Science ®Google Scholar
• Fan C-T, Lin J-C, Lee C-H. Taiwan Biobank: a project aiming to aid Taiwan’s transition into a biomedical island. Pharmacogenomics. 2008;9:235–246. doi:10.2217/14622416.9.2.235
   PubMed Web of Science ®Google Scholar
• Chen C-H, Yang J-H, Chiang CW, et al. Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Hum Mol Genet. 2016;25(24):5321–5331. doi:10.1093/hmg/ddw346
   PubMed Web of Science ®Google Scholar
• Hannon BA, Edwards CG, Thompson SV, et al. Genetic variants in lipid metabolism pathways interact with diet to influence blood lipid concentrations in adults with overweight and obesity. Lifestyle Genom. 2020;13(6):155–163. doi:10.1159/000507021
   PubMed Web of Science ®Google Scholar
• Jasim AA, Al-Bustan SA, Al-Kandari W, Al-Serri A, AlAskar H. Sequence analysis of APOA5 among the Kuwaiti population identifies association of rs2072560, rs2266788, and rs662799 with TG and VLDL levels. Front Genet. 2018;9:112. doi:10.3389/fgene.2018.00112
   PubMed Web of Science ®Google Scholar
• Villard EF, Eik P, Frisdal E, et al. Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels. Arterioscler Thromb Vasc Biol. 2013;33(4):822–828. doi:10.1161/ATVBAHA.112.300979
   PubMed Web of Science ®Google Scholar
• Shen Y, Xi B, Zhao X, et al. Common genetic variants associated with lipid profiles in a Chinese pediatric population. Hum Genet. 2013;132(11):1275–1285. doi:10.1007/s00439-013-1332-1
   PubMed Web of Science ®Google Scholar
• Aung LH, Yin RX, Wu DF, Wang W, Wu JZ, Liu CW. Sex-specific association of the zinc finger protein 259 rs2075290 polymorphism and serum lipid levels. Int J Med Sci. 2014;11(5):471–478. doi:10.7150/ijms.8489
   PubMed Web of Science ®Google Scholar
• Gombojav B, Lee SJ, Kho M, Song YM, Lee K, Sung J. Multiple susceptibility loci at chromosome 11q23.3 are associated with plasma triglyceride in East Asians. J Lipid Res. 2016;57(2):318–324. doi:10.1194/jlr.P063461
   PubMed Web of Science ®Google Scholar
• Guan F, Niu Y, Zhang T, et al. Two-stage association study to identify the genetic susceptibility of a novel common variant of rs2075290 in ZPR1 to type 2 diabetes. Sci Rep. 2016;6(1):29586. doi:10.1038/srep29586
   PubMedGoogle Scholar
• Brautbar A, Covarrubias D, Belmont J, et al. Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. Atherosclerosis. 2011;219(2):737–742. doi:10.1016/j.atherosclerosis.2011.08.015
   PubMed Web of Science ®Google Scholar
• Miazgowski T, Krzyżanowska-świniarska B, Dziwura-Ogonowska J, Widecka K. The associations between cardiometabolic risk factors and visceral fat measured by a new dual-energy X-ray absorptiometry-derived method in lean healthy Caucasian women. Endocrine. 2014;47(2):500–505. doi:10.1007/s12020-014-0180-7
   PubMed Web of Science ®Google Scholar
• Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(5):367–377. doi:10.1038/nrm2391
   PubMed Web of Science ®Google Scholar
• Yudkin J, Forrest R, Jackson C. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington diabetes survey. Lancet. 1988;332(8610):530–533. doi:10.1016/S0140-6736(88)92657-8
   Google Scholar
• Lee SH, Lee TW, Ihm CG, Kim MJ, Woo JT, Chung JH. Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation. Nephrology. 2005;10:S32–S36. doi:10.1111/j.1440-1797.2005.00454.x
   PubMed Web of Science ®Google Scholar
• Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–3488.
   PubMed Web of Science ®Google Scholar
• Clausen P, Jensen J, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation. 2001;103(14):1869–1874. doi:10.1161/01.CIR.103.14.1869
   PubMed Web of Science ®Google Scholar
• Stehouwer CA, Zeldenrust G, den Ottolander GH, Hackeng W, Donker A, Nauta J. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. lancet. 1992;340(8815):319–323. doi:10.1016/0140-6736(92)91401-S
   PubMed Web of Science ®Google Scholar
• Roest M, Banga JD, Janssen WM, et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation. 2001;103(25):3057–3061. doi:10.1161/hc2501.091353
   PubMed Web of Science ®Google Scholar
• Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110(1):32–35. doi:10.1161/01.CIR.0000133312.96477.48
   PubMed Web of Science ®Google Scholar
• Arnlov J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112(7):969–975. doi:10.1161/CIRCULATIONAHA.105.538132
   PubMed Web of Science ®Google Scholar
• Yamagata K, Yamagata Y, Kobayashi M, Koyama A. A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol. 1996;45(5):281–288.
   PubMed Web of Science ®Google Scholar
• Diercks GF, Hillege HL, van Boven AJ, et al. Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes. J Am Coll Cardiol. 2002;40(8):1401–1407. doi:10.1016/S0735-1097(02)02165-4
   PubMed Web of Science ®Google Scholar
• Mullens W, Damman K, Testani JM, et al. Evaluation of kidney function throughout the heart failure trajectory–a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22(4):584–603. doi:10.1002/ejhf.1697
   PubMed Web of Science ®Google Scholar
• Singh AN, Gasman B. Disentangling the genetics of sarcopenia: prioritization of NUDT3 and KLF5 as genes for lean mass & HLA-DQB1-AS1 for hand grip strength with the associated enhancing SNPs & a scoring system. BMC Med Genet. 2020;21(1):1–11. doi:10.1186/s12881-020-0977-6
   PubMed Web of Science ®Google Scholar
• Rutledge JC, Ng KF, Aung HH, Wilson DW. Role of triglyceride-rich lipoproteins in diabetic nephropathy. Nat Rev Nephrol. 2010;6(6):361. doi:10.1038/nrneph.2010.59
   PubMed Web of Science ®Google Scholar
• Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb. 1991;11(5):1192–1203. doi:10.1161/01.ATV.11.5.1192
   PubMedGoogle Scholar
• Svensson M, Eriksson JW. Insulin resistance in diabetic nephropathy—cause or consequence? Diabetes Metab Res Rev. 2006;22(5):401–410. doi:10.1002/dmrr.648
   PubMed Web of Science ®Google Scholar
• Mooradian AD, Haas MJ, Wehmeier KR, Wong NC. Obesity‐related changes in high‐density lipoprotein metabolism. Obesity. 2008;16(6):1152–1160. doi:10.1038/oby.2008.202
   PubMed Web of Science ®Google Scholar
• Dron JS, Wang J, Cao H, et al. Severe hypertriglyceridemia is primarily polygenic. J Clin Lipidol. 2019;13(1):80–88. doi:10.1016/j.jacl.2018.10.006
   PubMed Web of Science ®Google Scholar
• Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(2):160–167. doi:10.1161/01.ATV.0000054658.91146.64
   PubMed Web of Science ®Google Scholar
• Nieuwdorp M, Meuwese MC, Mooij HL, et al. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J Appl Physiol. 2008;104(3):845–852. doi:10.1152/japplphysiol.00440.2007
   PubMed Web of Science ®Google Scholar
• Davies BS, Beigneux AP, Barnes RH II, et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab. 2010;12(1):42–52. doi:10.1016/j.cmet.2010.04.016
   PubMed Web of Science ®Google Scholar
• Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol. 1999;19(3):472–484. doi:10.1161/01.ATV.19.3.472
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ichihara S, Kato K, et al. Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people. J Med Genet. 2008;45(1):22–28. doi:10.1136/jmg.2007.052415
   PubMed Web of Science ®Google Scholar
• Kawanami D, Matoba K, Utsunomiya K. Dyslipidemia in diabetic nephropathy. Ren Replace. 2016;2(1):1–9. doi:10.1186/s41100-016-0028-0
   Google Scholar
• Wheeler D, Fernando R, Gillett M, et al. Characterisation of the binding of low-density lipoproteins to cultured rat mesangial cells. Nephrol Dial Transplant. 1991;6(10):701–708. doi:10.1093/ndt/6.10.701
   PubMed Web of Science ®Google Scholar
• Gröne H-J, Walli AK, Gröne E, Krämer A, Clemens MR, Seidel D. Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int. 1990;37(6):1449–1459. doi:10.1038/ki.1990.135
   PubMed Web of Science ®Google Scholar
• Quaschning T, Königer M, Krämer-Guth A, et al. Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cells. Nephrol Dial Transplant. 1997;12(12):2528–2536. doi:10.1093/ndt/12.12.2528
   PubMed Web of Science ®Google Scholar
• Nishida Y, Oda H, Yorioka N. Effect of lipoproteins on mesangial cell proliferation. Kidney Int. 1999;56:S51–S53. doi:10.1046/j.1523-1755.1999.07113.x
   Web of Science ®Google Scholar
• Nosadini R, Tonolo G. Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr Metab Cardiovasc. 2011;21(2):79–85. doi:10.1016/j.numecd.2010.10.002
   PubMed Web of Science ®Google Scholar
• Leoncini G, Sacchi G, Ravera M, et al. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J Hum Hypertens. 2002;16(6):399–404. doi:10.1038/sj.jhh.1001408
   PubMed Web of Science ®Google Scholar